Send me a link:

*Text messaging rates may apply.

 Dow Down 0.80% Nasdaq Down 0.56%

Novo Nordisk A/S (NVO)

-NYSE
45.93 Up 0.46(1.01%) 2:53PM EDT - Nasdaq Real Time Price
Prev Close:45.47
Open:45.96
Bid:45.95 x 300
Ask:45.96 x 200
1y Target Est:49.37
Beta:1.04
Next Earnings Date:N/A
Day's Range:45.63 - 46.01
52wk Range:32.20 - 48.42
Volume:390,992
Avg Vol (3m):867,587
Market Cap:121.37B
P/E (ttm):26.43
EPS (ttm):1.74
Div & Yield:0.61 (1.30%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVOUp 1.01%121.37B
LLYDown 1.15%68.26B
PFEDown 0.58%192.41B
SNYDown 1.90%134.82B

Key Statistics

Forward P/E (1 yr):22.31
P/S (ttm):7.93
Ex-Dividend Date:21-Mar-14

Analysts

Annual EPS Est (Dec-14) :1.85
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback